Journal Guide

Devoted exclusively to the study of the molecular biology, biochemistry, immunology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins, interferons, and new cytokines, Cytokine provides comprehensive coverage of cytokines and their receptors, 12 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors.Special issues:Suggestions for special issue topics and guest editors can be sent to Paul Taylor, p.taylor@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cytotherapy is the Official Journal of the International Society for Cellular Therapy (ISCT).Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, physicians, and regulatory experts involved in cell processing and therapy.The journal's scope includes research in:Stem cell processing and transplantationCell-based therapies of malignant and non-malignant blood diseasesCancerStem cell plasticityAutoimmune diseasesImmunotherapyCongenital disordersNovel molecular therapiesGene therapyMicrovesicle biology and therapeutic application

Developmental and Comparative Immunology (DCI) is an international journal that publishes articles describing original research in all areas of immunology, including comparative aspects of immunity and the evolution and development of the immune system. Manuscripts describing studies of immune systems in both vertebrates and invertebrates are welcome. All levels of immunological investigations are appropriate: organismal, cellular, biochemical and molecular genetics, extending to such fields as aging of the immune system, interaction between the immune and neuroendocrine system and intestinal immunity.Please bookmark this URL: http:/www.elsevier.com/locate/devcompimmBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology. The journal examines new procedures, unusual cases, controversial issues, and important new literature.Diagnostic Microbiology and Infectious Disease's distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.Diagnostic Microbiology and Infectious Disease features:– Informed commentaries on new antibiotics– Rapid and cost-effective methods in the laboratory– Instructive case studies with emphasis on complex circumstances– Insightful editorials on important current issues– Book reviews that keep you up-to-date on recently published literature.Diagnostic Microbiology and Infectious Disease also covers such areas as laboratory and clinical management of microbial diseases, epidemiology and pathogenesis of infections, automation in the diagnostic microbiology laboratory, and antibiotic susceptibility testing.

Disease Models & Mechanisms (DMM) is an Open Access biomedical research journal focusing on the use of model systems to better understand, diagnose and treat human disease. The primary aim of DMM is to promote human health by inspiring collaboration between basic and clinical researchers in translational science. The journal is committed to presenting rigorously peer-reviewed research that has significant translational impact. The interdisciplinary nature of DMM means that a diverse range of diseases, approaches and models fall within its broad scope. DMM is guided by an international team of expert research-active Editors, led by Editor-in-Chief Elizabeth Patton and Deputy Editor-in-Chief Elaine Mardis, and supported by an outstanding Editorial Advisory Board.

Doklady Biological Sciences is a journal containing English translations of current Russian research in molecular biology, cell biology, microbiology, immunology, physiology, general biology and botanics, published in the corresponding sections of the Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences). The Proceedings appear 36 times a year, articles from the selected biological sections are collected, translated, and published in 6 issues a year. Doklady Biological Sciences publishes the most significant new research in the biological sciences being done in Russia today, thus ensuring its scientific priority.The Editorial Board of Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences) accepts new articles in the Russian language, formatted in accordance with the Rules for Authors. The article must be presented for publication by acting Russian or foreign members of the Russian Academy of Sciences.

The journal provides an effective way to publish research and review articles, short communications and technical notes, Video material, animation sequences and 3D are also accepted to support and enhance articles. The articles will be examined by a scientific committee and anonymous evaluators and published every two months in HTML and PDF formats (January 15th , March 15th, May 15th, July 15th, September 15th, November 15th).

The following areas are covered in the Journal:
• Animal Biotechnology
• Bioethics
• Biofilms
• Bioinformatics
• Biopolicies of International Cooperation
• Biosafety
• Biotechnology Industry
• Biotechnology of Human Disorders
• Chemical Engineering
• Environmental Biotechnology
• Food Biotechnology
• Marine Biotechnology
• Medical Biotechnology
• Microbial Biotechnology
• Molecular Biology and Genetics
• Plant Biotechnology
• Process Biotechnology
• Process Chemistry and Technology

Electronic Journal of Biotechnology is a http://publicationethics.org/members/peerjfull Member of the Committee on Publication Ethics (http://publicationethics.org/COPE).

Welcome to the Centers for Disease Control and Prevention. For over 60 years, CDC has been dedicated to protecting health and promoting quality of life through the prevention and control of disease, injury, and disability. We are committed to programs that reduce the health and economic consequences of the leading causes of death and disability, thereby ensuring a long, productive, healthy life for all people.

Emerging Microbes & Infections (EMI) is a new open access, fully peer-reviewed international journal. The purpose of EMI is to provide a forum to publish a wide range of scientific reports related to emerging infectious diseases, especially with new information from developing countries where such diseases are constantly arising and being discovered regularly. It will report discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders. Original articles related to Immune Disorders and Drug Targeting are also considered for publication.

Environmental Microbiology provides a high profile vehicle for publication of the most innovative, original and rigorous research in the field. The scope of the Journal encompasses the diversity of current research on microbial processes in the environment, microbial communities and microbial interactions, including, but not limited to, the following: the structure, activities and communal behaviour of microbial communities microbial interactions and interactions with plants, animals and non-living environmental factors population biology and clonal structure microbes and surfaces adhesion and biofouling responses to environmental signals and stress factors growth and survival modelling and theory development microbial community genetics and evolutionary processes microbial physiological, metabolic and structural diversity pollution microbiology extremophiles and life in extreme and unusual little-explored habitats primary and secondary production element cycles and biogeochemical processes microbially-influenced global changes new technological developments in microbial ecology, in particular for the study of activities of microbial communities and of non-culturable microorganisms Interdisciplinary studies of fundamental problems are particularly welcome.

The journal is identical in scope to Environmental Microbiology, shares the same editorial team and submission site, and will apply the same high level acceptance criteria. The two journals will be mutually supportive and evolve side-by-side. Environmental Microbiology Reports provides a high profile vehicle for publication of the most innovative, original and rigorous research in the field. The scope of the Journal encompasses the diversity of current research on microbial processes in the environment, microbial communities and microbial interactions, including, but not limited to, the following:

Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells.We especially encourage submissions on:Biocatalysis and the use of Directed Evolution in Synthetic Biology and BiotechnologyBiotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and BiofuelsNew Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems BiologyNew Biotechnological Approaches in Genomics, Proteomics and MetabolomicsMetabolic Engineering, Biomolecular Engineering and NanobiotechnologyManuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.

Epidemics publishes papers on infectious disease dynamics in the broadest sense. Its scope covers both within-host dynamics of infectious agents and dynamics at the population level, particularly the interaction between the two. Areas of emphasis include: spread, transmission, persistence, implications and population dynamics of infectious diseases; population and public health as well as policy aspects of control and prevention; dynamics at the individual level; interaction with the environment, ecology and evolution of infectious diseases, as well as population genetics of infectious agents.The journal will only publish papers that use high quality novel or published data in their analysis. Successful manuscripts are typically multidisciplinary and integrative. Methodological manuscripts are only acceptable if they present a clear and relevant biological application for which novel insight is gained.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Excellence in medical and scientific information.A leader in the field of medical publishing for the past 20 years, John Libbey Eurotext has compiled a prestigious catalogue of books and publishes more than 60 new titles every year. A wide variety of series: scientific meeting reports, monographs and practical guides both aimed at general practioners and specialists.